CDC reviews post Covid vaccination myocarditis in adolescents and young adults, “3rd leading cause of Sudden Death in children and young adults”, “inflammation enlarges and weakens the heart, creates scar tissue”
“it is universally known that children virtually never die from COVID-19 and given that children have a very strong immune system, they are more likely than adults to have an over-reaction to the shot.”…Dr. Steven Roth
“Why are we vaccinating healthy adults when 81 percent of Covid-19 cases are mild and there is a 99 percent survival rate. Why are we testing vaccines on children who are minimally impacted by the disease?”…Citizen Wells
“By looking at the difference between adults and children in these quarantines, deCODE found that children play a minor role in transmission.”…Iceland Covid transmission study
From the CDC.
“The VaST session on May 17, 2021, included several presentations on myocarditis following mRNA vaccines, from the Department of Defense (DoD), the Vaccine Adverse Event Reporting System (VAERS), and Vaccine Safety Datalink (VSD). There were also brief updates from the Veteran’s Administration (VA) and the Clinical Immunization Safety Assessment (CISA) groups about their plans for future investigation of myocarditis.
VaST concluded that there are relatively few reports of myocarditis to date and that these cases seem to occur:
- predominantly in adolescents and young adults,
- more often in males than females,
- more often following dose 2 than dose 1, and
- typically within 4 days after vaccination.
Most cases appear to be mild, and follow-up of cases is ongoing.
Within CDC safety monitoring systems, rates of myocarditis reports in the window following COVID-19 vaccination have not differed from expected baseline rates. However, VaST members felt that information about reports of myocarditis should be communicated to providers.
VaST discussed:
- Further information should be collected through medical record review about potential myocarditis cases that were reported into VAERS.
- Information about this potential adverse event should be provided to clinicians to enhance early recognition and appropriate management of persons who develop myocarditis symptoms following vaccination.
- Collaboration between infectious diseases, cardiology, and rheumatology specialists is needed to provide guidance on diagnosis, treatment, and management of myocarditis.”
https://www.cdc.gov/vaccines/acip/work-groups-vast/technical-report-2021-05-17.html
From the Myocarditis Foundation.
“In simple terms, myocarditis is a disease that causes inflammation of the heart muscle. This inflammation enlarges and weakens the heart, creates scar tissue and forces it to work harder to circulate blood and oxygen throughout the body.
While we often associate cardiovascular conditions with elderly populations, myocarditis can affect anyone, including young adults, children and infants. In fact, it most often affects otherwise healthy, young, athletic types with the high-risk population being those of ages from puberty through their early 30’s, affecting males twice as often as females. Myocarditis is the 3rd leading cause of Sudden Death in children and young adults.”
Read more:
https://www.myocarditisfoundation.org/about-myocarditis/
More here:
Citizen WElls 